DEVELOPING COMBINATION THERAPEUTICS FOR CHRONIC AND NEUROPATHIC PAIN

AT TRINITY, we are dedicated to making safer and more effective combination therapies that are more accessible to those suffering from chronic and neuropathic pain.

WHAT IS COMBINATION THERAPY?

tricombi COMBINATION THERAPY means the simultaneous administration of two or more drugs to treat a single disease. The major advantages of the combination therapy are the following:

  •  Exert synergistic effect to relieve the symptoms of a disease
  •  Require lower doses than individual drugs alone
  •  Drug combinations target diverse mechanisms related to all aspects of individual drug action
  •  Fewer harmful side effects or dose-limiting toxicities
  •  Greater therapeutic effect
  •  Lower treatment failure rate
  •  Lower case-fatality ratios and slower development of resistance

Learn More >

COMBINATION THERAPY DRUGS

We develop COMBINATION THERAPY drugs using our expertise that enables high therapeutic efficacy and minimal toxicity for treating chronic and neuropathic pain in humans.
Learn More >

Latest News

01/20/2014

Trinity Laboratories announces the issuance of core patent US 8,604,082 for the treatment of premature ejaculation in humans in the US. The core patent is pending in the EU and Japan.

Learn More >